RoosterBio looks forward to meeting with many of our peers for the 5th annual Exosome-Based Therapeutic Development Summit in Boston, MA, and we invite attendees to stop by our booth to chat with our team. Attend the poster session on September 7th at 10:30 am if you’d like to learn more about our work in collaboration with Repligen Corporation on the “Development of Manufacturing Therapeutic Platform for EVs Derived from MSC Using Tangential Flow Depth Filtration & Tangential Flow Filtration.”

On Wednesday, September 6th at 12:30 pm, speaker and CEO of RoosterBio, Tim Kelly will present, “Approaches for Scalable Purification & Analytical Characterization for cGMP Manufacture of Exosomes” to discuss the following:

• Scalable, functionally closed unit operations throughout the upstream and downstream process simplifies the transition to cGMP manufacturing and enables the production of therapeutically relevant quantities of exosomes
• Maximize yield while maintaining product quality to achieve effective cost of goods
• Utilize a broad panel of comprehensive analytical techniques to ensure critical quality attributes are met during production and in the final drug product